BioSpace News Archive

Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia (sHTG) (triglyceride blood levels from 500 mg/dL to 1500 mg/dL), today provided a business update and announced its operating and financial results for the first quarter

Emerald Bioscience, Inc. (OTCQB: EMBI) (“Emerald” or the “Company”), a preclinical-stage biopharmaceutical company focused on the development of proprietary first-in-class molecules with strong clinical and commercial differentiation, today announced the appointment of Margaret R. Dalesandro, Ph.D., to the Company’s Board of Directors. Dr. Dalesandro brings more than 25 years of drug development experience in pharmaceutical, biotechnology a

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that the European Medicines Agency (EMA) validated the Company’s Marketing Authorization Application (MAA) for vosoritide, an investigational, once daily injection analog of C-type Natriuretic Peptide (CNP) for children with achondroplasia

Milestone Scientific Inc. (NYSE American:MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Monday, August 17, 2020 to discuss the Companys financial results for the second quarter ended June 30, 2020, as well as the Companys corporate progress and other developments.

Dutch Ridge Consulting Group (DRCG), LLC, a Service-Disabled, Veteran-Owned Small Business (SDVOSB) headquartered in Beaver, PA, today announced that it has reached a distribution agreement for the Sienna™ COVID-19 IgG/IgM Rapid Test Cassette.

Progenabiome, a Ventura-based genetic sequencing research lab, welcomes two new advisory board members: Sheldon Jordan, MD, and Alexander Bystritsky, MD, PhD. Progenabiome is dedicated to understanding the clinical implications of the microbiome.

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the UBS Genomics 2.0 and MedTech Innovations Virtual Summit on Thursday, August 13, 2020 , at 3:30 p.m. ET . A live webcast of BD’s presentation can be accessed from the BD corporate website

ValhallaMED, a manufacturer of MedTech devices designed to fight COVID-19, today announced the first-of-its-kind personal protective gear with air filtration and full face coverage — the NE-1 Helmet™

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that it and partner OntoChem have identified additional candidates through their in silico screening study. In addition to four compounds that target an endoribonuclease (als

AGC Biologics, a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced it is partnering with Ono Pharmaceutical Co., Ltd. (ONO) to manufacture new, innovative biopharmaceuticals at the clinical development stage. ONO is a R&D-oriented pharmaceutical company committed to discovering and developin